A different approach to analyzing age-related HbA1c values in non-diabetic subjects

Clinical Chemistry and Laboratory Medicine

Volumn 42, Issue 4, 2004, Pages 423-428

  Polneau, Sandrine Vallée ^a,b,e   Lasserre, Virginie ^b   Fonfrède, Michèle ^c   Delattre, Jacques ^c   Bénazeth, Simone ^d  

^a Lab de Statisque Info Biophysique   (France)

^b 5 R Jean Baptiste Clment 92296 C   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Laboratoire de Pharmacognosie   (France)

^e NONE   (France)

Author keywords

Age; Hemoglobin A1c; Relationship

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HEXOKINASE;

ACCURACY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALYTIC METHOD; ARTICLE; CALCULATION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ASSAY; FEMALE; FRANCE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTHESIS; ION EXCHANGE CHROMATOGRAPHY; KOLMOGOROV SMIRNOV TEST; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MALE; NORMAL DISTRIBUTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STUDENT T TEST;

ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD GLUCOSE; BODY MASS INDEX; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HEXOKINASE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES;

EID: 2342629317     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2004.074     Document Type: Article

References (13)

1. Fonfrède M, Chevenne D. Rôle du laboratoire dans le dépistage, le diagnostic et le suivi du diabète sucré. Lab-med 2001;452-61.
2. Greenberg RA, Sacks DB. Screening for diabetes: is it warranted? Clin Chim Acta 2002;315:61-9.
3. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. UKPDS Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. The Lancet 1998;352:837-53.
5. Chanson P, Timsit J, Charbonnel B. Données actualisées de I'UKPDS: implications pour la prise en charge des patients diabétiques de type 2. Traitement du diabète de type 2 Médecine thérapeutique. Endocrinologie 2000;2:207-16.
6. Gillery P, Delpech M, Garcia I, Vague P, Dezier JF, Périer C. Evaluation des méthodes de dosage de l'hémoglobine glyquée: méthode et paramètre de réfé rence. Ann Biol Clin 1995;53:395-8.
7. Revenant MC. Hemoglobine glyquée: méthodes de dosage et intérêt. Lyon Pharmaceutique 1997;48:286-92.
8. Little RR, Rohlfing CL, Wiedmeyer H, Myers GL, Sacks DB, Goldstein DE, for the NGSP Steering Committee: The National Glycohemoglobin Standardisation Program. A five-year progress report. Clin Chem 2001; 47:1985-91.
9. 1c in human blood. Clin Chem Lab Med 2002;40:78-89.
10. 1c: concertation clinico-biologique pour la standardisation des méthodes de dosage. Rapport des experts de I'ALFEDIAM et de la SFBC. Diabetes Metab (Paris) 1999;25:283-7.
11. Gillery P, Dumont G, Vassault A. Evaluation of GHb assays in France by National Quality Control Surveys. Diabetes Care 1998;21:265-70.
12. Gerlo E, Gorus F. Calibration of ion-exchange HPLC measurements of glycohemoglobin: effect on interassay precision. Clin Chem 1997;43:2353-7.
13. Recommandations ANAES Service évaluation des Technologies, Service évaluation économique. Principe de dé pistage du diabète de type 2. February 2003. Available from http://www.anaes.fr/ANAES/anaesparametrage.nsf/accueilnouveautes?readform